Louis Reese
Founder presso VAXXINITY, INC.
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Louis G.
Reese is the founder of Vaxxinity, Inc. founded in 2014, where he holds the title of Executive Chairman.
He currently holds positions as Co-Chief Executive Officer & Director at United Biomedical, Inc., Executive Chairman at Covaxx, Inc., and Director at C19 Corp.
In the past, he held the position of Director at Madison Partners LLC and Director at Shen Lian Biotechnology Co. Ltd.
from 2010 to 2014.
Mr. Reese received an undergraduate degree from the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VAXXINITY INC CLASS B
28.51% | 31/12/2023 | 3 955 512 ( 28.51% ) | 3 M $ | 31/03/2024 |
VAXXINITY INC CLASS A
0.02% | 31/12/2023 | 17 500 ( 0.02% ) | 12 548 $ | 31/03/2024 |
Posizioni attive di Louis Reese
| Società | Posizione | Inizio |
|---|---|---|
| VAXXINITY, INC. | Founder | 01/01/2014 |
United Biomedical, Inc.
 United Biomedical, Inc. Pharmaceuticals: MajorHealth Technology United Biomedical, Inc. manufactures biological vaccines and other immunizing products. It engages in discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. The firm’s vaccines are used for the treatment and prevention of alzheimer’s disease, AIDS, and allergy, along with a portfolio of animal health diseases. The company was founded by Nean Hu and Chang Yi Wang in 1985 and is headquartered in Hauppauge, NY. | Chief Executive Officer | - |
C19 Corp.
 C19 Corp. BiotechnologyHealth Technology C19 Corp. operates as a biotechnology company. The company is headquartered in Hauppauge, NY. | Director/Board Member | - |
Covaxx, Inc.
 Covaxx, Inc. BiotechnologyHealth Technology Covaxx, Inc. is a vaccine development company that focuses on creating vaccines for COVID-19, neurological disorders such as Alzheimer's and Parkinson's diseases, as well as prevalent chronic disorders like migraine and hypercholesterolemia. The private company is based in Dallas, TX, with operations in other locations. Covaxx recently consolidated with United Neuroscience to form a new holding company called Vaxxinity, Inc. Vaxxinity's lead candidate in its pipeline is UB-612, a vaccine candidate to fight SARS-CoV-2. Additionally, Vaxxinity has deployed hundreds of thousands of SARS-CoV-2 ELISA tests, which have received FDA emergency use authorization (EUA). The company was founded in 2020 by Peter H. Diamandis, and the CEO is Mei Mei Hu. | Chairman | - |
Precedenti posizioni note di Louis Reese
| Società | Posizione | Fine |
|---|---|---|
| Shen Lian Biotechnology Co. Ltd. | Director/Board Member | 01/01/2014 |
Madison Partners LLC
 Madison Partners LLC Real Estate DevelopmentFinance Madison Partners LLC provides real estate brokerage services. The private company is based in Dallas, TX. | Director/Board Member | - |
Formazione di Louis Reese
| University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VAXXINITY, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
United Biomedical, Inc.
United Biomedical, Inc. Pharmaceuticals: MajorHealth Technology United Biomedical, Inc. manufactures biological vaccines and other immunizing products. It engages in discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. The firm’s vaccines are used for the treatment and prevention of alzheimer’s disease, AIDS, and allergy, along with a portfolio of animal health diseases. The company was founded by Nean Hu and Chang Yi Wang in 1985 and is headquartered in Hauppauge, NY. | Health Technology |
Madison Partners LLC
Madison Partners LLC Real Estate DevelopmentFinance Madison Partners LLC provides real estate brokerage services. The private company is based in Dallas, TX. | Finance |
C19 Corp.
C19 Corp. BiotechnologyHealth Technology C19 Corp. operates as a biotechnology company. The company is headquartered in Hauppauge, NY. | Health Technology |
Covaxx, Inc.
Covaxx, Inc. BiotechnologyHealth Technology Covaxx, Inc. is a vaccine development company that focuses on creating vaccines for COVID-19, neurological disorders such as Alzheimer's and Parkinson's diseases, as well as prevalent chronic disorders like migraine and hypercholesterolemia. The private company is based in Dallas, TX, with operations in other locations. Covaxx recently consolidated with United Neuroscience to form a new holding company called Vaxxinity, Inc. Vaxxinity's lead candidate in its pipeline is UB-612, a vaccine candidate to fight SARS-CoV-2. Additionally, Vaxxinity has deployed hundreds of thousands of SARS-CoV-2 ELISA tests, which have received FDA emergency use authorization (EUA). The company was founded in 2020 by Peter H. Diamandis, and the CEO is Mei Mei Hu. | Health Technology |
| Shen Lian Biotechnology Co. Ltd. |
- Borsa valori
- Insiders
- Louis Reese
